Wen et al. investigated the prognostic role of ET-1 and endothelin A receptor (ETAR) gene polymorphisms in the blood samples of patients with locoregionally advanced NPC, and found that the ETAR/H323H polymorphism was a novel and independent prognostic marker [39]. The gene discussed is EDNRA; the disease is nasopharyngeal carcinoma.